MacroGenics Inc (MGNX) stock
MGNXNasdaqPharmaceutical PreparationsFiscal year ends December 31
$2.20−0.09 (-3.93%)
Close on Nov 13, 2026Market cap $140.14MP/E –Yield –
MacroGenics profit margin
Profit margin (net margin) is net income as a percentage of revenue.
MacroGenics's profit margin for the twelve months ending Sep 30, 2026 was -33.2%. For fiscal 2025 it was -49.9%, against -44.7% the year before. The highest annual figure on record is 13.1% in fiscal 2012.
Annual profit margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -49.9% | −5.3 |
| FY2024 | Dec 31, 2024 | -44.7% | −29.2 |
| FY2023 | Dec 31, 2023 | -15.4% | +63.4 |
| FY2022 | Dec 31, 2022 | -78.8% | +182.2 |
| FY2021 | Dec 31, 2021 | -261.0% | −137.3 |
| FY2020 | Dec 31, 2020 | -123.7% | +112.8 |
| FY2019 | Dec 31, 2019 | -236.5% | +48.7 |
| FY2018 | Dec 31, 2018 | -285.2% | −272.7 |
| FY2017 | Dec 31, 2017 | -12.4% | +51.3 |
| FY2016 | Dec 31, 2016 | -63.7% | −43.7 |
| FY2015 | Dec 31, 2015 | -20.0% | +60.2 |
| FY2014 | Dec 31, 2014 | -80.2% | −79.7 |
| FY2013 | Dec 31, 2013 | -0.4% | −13.6 |
| FY2012 | Dec 31, 2012 | 13.1% | +1.4 |
| FY2011 | Dec 31, 2011 | 11.7% | – |
Quarterly profit margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | -107.5% | −139.3 |
| Q2 FY2026 | Jun 30, 2026 | 59.4% | +587.2 |
| Q1 FY2026 | Mar 31, 2026 | -177.0% | +134.1 |
| Q4 FY2025 | Dec 31, 2025 | -17.1% | +62.5 |
| Q3 FY2025 | Sep 30, 2025 | 31.7% | −19.1 |
| Q2 FY2025 | Jun 30, 2025 | -527.7% | −12.2 |
| Q1 FY2025 | Mar 31, 2025 | -311.1% | +262.2 |
| Q4 FY2024 | Dec 31, 2024 | -79.7% | +350.1 |
| Q3 FY2024 | Sep 30, 2024 | 50.9% | −118.0 |
| Q2 FY2024 | Jun 30, 2024 | -515.6% | −953.0 |
| Q1 FY2024 | Mar 31, 2024 | -573.3% | −418.1 |
| Q4 FY2023 | Dec 31, 2023 | -429.8% | −447.3 |
| Q3 FY2023 | Sep 30, 2023 | 168.8% | +228.3 |
| Q2 FY2023 | Jun 30, 2023 | 437.5% | +596.3 |
| Q1 FY2023 | Mar 31, 2023 | -155.2% | +443.4 |
| Q4 FY2022 | Dec 31, 2022 | 17.5% | +427.6 |
| Q3 FY2022 | Sep 30, 2022 | -59.5% | +278.2 |
| Q2 FY2022 | Jun 30, 2022 | -158.8% | −29.0 |
| Q1 FY2022 | Mar 31, 2022 | -598.5% | −294.8 |
| Q4 FY2021 | Dec 31, 2021 | -410.1% | −406.2 |
| Q3 FY2021 | Sep 30, 2021 | -337.7% | −140.2 |
| Q2 FY2021 | Jun 30, 2021 | -129.8% | +101.6 |
| Q1 FY2021 | Mar 31, 2021 | -303.7% | +23.2 |
| Q4 FY2020 | Dec 31, 2020 | -4.0% | +116.7 |
| Q3 FY2020 | Sep 30, 2020 | -197.5% | +40.7 |
| Q2 FY2020 | Jun 30, 2020 | -231.5% | +68.4 |
| Q1 FY2020 | Mar 31, 2020 | -326.9% | +139.0 |
| Q4 FY2019 | Dec 31, 2019 | -120.7% | +162.0 |
| Q3 FY2019 | Sep 30, 2019 | -238.1% | −74.5 |
| Q2 FY2019 | Jun 30, 2019 | -299.9% | −70.3 |
| Q1 FY2019 | Mar 31, 2019 | -465.9% | +589.2 |
| Q4 FY2018 | Dec 31, 2018 | -282.7% | −352.1 |
| Q3 FY2018 | Sep 30, 2018 | -163.6% | +2665.2 |
| Q2 FY2018 | Jun 30, 2018 | -229.6% | +2210.6 |
| Q1 FY2018 | Mar 31, 2018 | -1055.1% | +777.3 |
| Q4 FY2017 | Dec 31, 2017 | 69.4% | +750.6 |
| Q3 FY2017 | Sep 30, 2017 | -2828.8% | – |
| Q2 FY2017 | Jun 30, 2017 | -2440.2% | – |
| Q1 FY2017 | Mar 31, 2017 | -1832.4% | – |
| Q4 FY2016 | Dec 31, 2016 | -681.2% | – |
See a number that looks wrong?